Precision Oncology: Translating Discovery to the Clinic | EK45



Sessions

Harnessing Tumor Evolution and Immune Responses to Treat Lung Cancer

Speaker(s):

Emerging Technologies I iconEmerging Technologies I

Preview Available

Emerging Technologies I

Co-Chair(s):

Single Cell Genomics Technologies in the Clinic – Challenges and Opportunities

Speaker(s):

Biology and Vulnerabilities of Circulating Tumor Cells

Speaker(s):

Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer

Speaker(s):
  • Cigall Kadoch, PhD, Dana-Farber Cancer Institute, Harvard Medical School

Short Talk: Nano-Targeted Kinase Inhibitor Treatment of KRAS Mutant Lung Cancer

Speaker(s):

Short Talk: A Metastasis Map of Human Cancer Cell Lines

Speaker(s):
  • Xin Jin, BS, Broad Institute of MIT and Harvard

Coffee Break iconCoffee Break

Preview Available

Coffee Break


Resistance to Non-Small Cell Lung Cancer Therapies

Speaker(s):
  • Alice T. Shaw, MD, PhD, Novartis Institutes for Biomedical Research, Inc.

Clinical Trials and Overcoming Resistance

Co-Chair(s):